Loading clinical trials...
Loading clinical trials...
Standard placebo-controlled, double-blind study design (TEV-50717 \[low dose and high dose\] vs. placebo in a 1:1:1 ratio) was chosen to determine whether study drug treatment results in a statistical...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators
NCT05558566 · Tourette Syndrome in Adolescence
NCT06678737 · Tics, Tourette Syndrome
NCT06585618 · Dystonia, Epilepsy in Children, and more
NCT03851484 · Tourette Syndrome
NCT04449068 · Tourette Syndrome
Teva Investigational Site 060-0160
Gainesville, Florida
Teva Investigational Site 060-0166
Gulf Breeze, Florida
Teva Investigational Site 060-0161
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions